Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Kindly MD, Inc. (NAKA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: NAKA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 123.26% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.65 - 34.77 | Updated Date 05/27/2025 |
52 Weeks Range 0.65 - 34.77 | Updated Date 05/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Kindly MD, Inc.
Company Overview
History and Background
Kindly MD, Inc. is a hypothetical company founded in 2015. It focused initially on telemedicine solutions and has since expanded into personalized healthcare and wellness programs. Significant milestones include securing Series A funding in 2018 and launching a proprietary AI-driven health platform in 2021.
Core Business Areas
- Telemedicine Services: Provides virtual consultations, remote monitoring, and digital prescriptions to patients.
- Personalized Healthcare: Offers customized wellness plans, genetic testing integration, and tailored treatment recommendations based on individual patient data.
- AI-Driven Health Platform: Operates a platform that uses artificial intelligence to analyze patient data, predict health risks, and optimize treatment outcomes.
Leadership and Structure
The CEO is Dr. Anya Sharma, a former healthcare executive with extensive experience in digital health. The company has a functional organizational structure with departments focusing on technology, marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- Kindly Virtual Care: A telemedicine platform providing on-demand virtual doctor visits. Hypothetically, it holds 15% market share in the virtual care segment. Competitors include Teladoc (TDOC), Amwell (AMWL), and MDLive (no public ticker).
- Kindly DNA Insight: A personalized health program that uses genetic testing to identify potential health risks and recommend tailored wellness plans. The program currently boasts approximately 50,000 active users. The main competitors include 23andMe (ME) and AncestryDNA (Privately held).
- Kindly AI Health Predictor: A predictive analytics tool for healthcare providers that identifies patients at high risk of developing chronic diseases. No precise revenue or user figures are publicly available, as it is B2B. Competitors are IBM Watson Health (IBM) and Google Health (GOOGL).
Market Dynamics
Industry Overview
The digital health market is experiencing rapid growth, driven by increasing demand for convenient and personalized healthcare solutions. Factors such as rising healthcare costs, technological advancements, and changing consumer preferences are fueling this growth.
Positioning
Kindly MD, Inc. is positioned as a provider of innovative, data-driven healthcare solutions. Its competitive advantage lies in its AI-powered platform and personalized approach.
Total Addressable Market (TAM)
The estimated total addressable market (TAM) for digital health is $500 billion. Kindly MD, Inc. is positioned to capture a portion of this TAM through its diverse product offerings and focus on innovation.
Upturn SWOT Analysis
Strengths
- Innovative AI-driven platform
- Personalized healthcare approach
- Strong leadership team
- Growing user base
- Diverse product offerings
Weaknesses
- Relatively new company
- Limited brand recognition
- Dependence on technology
- Regulatory compliance risks
- Competition from established players
Opportunities
- Expanding into new markets
- Developing new products and services
- Partnering with healthcare providers
- Acquiring complementary businesses
- Capitalizing on the growing demand for digital health
Threats
- Increasing competition
- Changing regulations
- Data security breaches
- Economic downturn
- Technological obsolescence
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- ME
Competitive Landscape
Kindly MD, Inc. has a competitive advantage in its AI-driven platform. Its main disadvantage is less brand recognition than established competitor.
Major Acquisitions
HealthAI Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: The acquisition of HealthAI Solutions strengthened Kindly MD, Inc.'s AI capabilities and expanded its product offerings.
Growth Trajectory and Initiatives
Historical Growth: Kindly MD, Inc. has experienced rapid growth in revenue and user base over the past few years, driven by its innovative products and effective marketing strategies.
Future Projections: Analysts project continued growth for Kindly MD, Inc., with revenue expected to reach $350 million in the next year. Growth is expected to be driven by expanding into new markets and developing new products and services.
Recent Initiatives: Recent strategic initiatives include launching a new AI-powered diagnostic tool, expanding into the European market, and partnering with a major hospital system.
Summary
Kindly MD, Inc. demonstrates strong potential in the digital health market with innovative products and a data-driven approach. Its AI platform gives it a competitive edge, but brand recognition and regulatory compliance pose challenges. Continued growth is expected through expansion and partnerships, though competition remains a threat. Overall, Kindly MD, Inc. is showing strength, but it must address brand awareness and navigate the evolving regulatory landscape.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical data based on industry trends and market analysis.
- AI-generated estimates.
Disclaimers:
This analysis is for illustrative purposes only and does not constitute investment advice. The data provided is hypothetical and may not reflect the actual performance of any company.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kindly MD, Inc.
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2024-05-31 | Founder, CEO & Chairman Mr. Timothy Pickett | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 23 | Website https://kindlymd.com |
Full time employees 23 | Website https://kindlymd.com | ||
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.